References
- Anna P, Isabelle B, Romain C, et al. Levels of evidence supporting United States guidelines in pancreatic adenocarcinoma treatment. Cancers. 2022;14(16):4062.
- GBD 2017 Pancreatic Cancer Collaborators. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2019;4(12):934–947.
- Cronin KA, Scott S, Firth AU, et al. Annual report to the nation on the status of cancer, part 1: national cancer statistics. Cancer. 2022;128(24):4251–4284.
- Mouratidis Petros XE, ter Haar G. Latest advances in the use of therapeutic focused ultrasound in the treatment of pancreatic cancer. Cancers (Basel). 2022;14(3):638.
- Vidal-Jove J, Perich E, Del Castillo MA. Ultrasound guided high intensity focused ultrasound for malignant tumors: the spanish experience of survival advantage in stage III and IV pancreatic cancer. Ultrason Sonochem. 2015;27:703–706.
- Ning Z, Xie J, Chen Q, et al. HIFU is safe, effective, and feasible in pancreatic cancer patients: a monocentric retrospective study among 523 patients. Onco Targets Ther. 2019;112:1021–1029.
- Marinova M, Feradova H, Gonzalez-Carmona MA, et al. Improving quality of life in pancreatic cancer patients following high-intensity focused ultrasound (HIFU) in two European centers. Eur Radiol. 2021;31(8):5818–5829.
- Wang K, Chen Z, Meng Z, et al. Analgesic effect of high intensity focused ultrasound therapy for unresectable pancreatic cancer. Int J Hyperthermia. 2011;27(2):101–107.
- Wang K, Chen L, Meng Z, et al. High intensity focused ultrasound treatment for patients with advanced pancreatic cancer: a preliminary dosimetric analysis. Int J Hyperthermia. 2012;28(7):645–652.
- Cardella JF, Kundu S, Miller DL, et al. Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol. 2009;20(7 Suppl):S189–S191.
- Martin RC, 2nd, Kwon D, Chalikonda S, et al. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy. Ann Surg. 2015;262(3):486–494.
- Spiliopoulos S, Zurlo MT, Casella A, et al. Current status of non-surgical treatment of locally advanced pancreatic cancer. World J Gastrointest Oncol. 2021;13(12):2064–2075.
- Bazeed AY, Day CM, Garg S. Pancreatic cancer: challenges and opportunities in locoregional therapies. Cancers (Basel). 2022;14(17):4257.
- Blomstrand H, Batra A, Cheung WY, et al. Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer. World J Clin Oncol. 2021;12(9):787–799.
- Hall BR, Cannon A, Atri P, et al. Advanced pancreatic cancer: a meta- analysis of clinical trials over thirty years. Oncotarget. 2018;9(27):19396–19405.
- Comito T, Cozzi L, Clerici E, et al. Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study. Technol Cancer Res Treat. 2017;16(3):295–301.
- van Veldhuisen E, van den Oord C, Brada LJ, et al. Locally advanced pancreatic cancer: work-up, staging, and local intervention strategies. Cancers (Basel). 2019; Jul 1211(7):976.
- Saccomandi P, Lapergola A, Longo F, et al. Thermal ablation of pancreatic cancer: a systematic literature review of clinical practice and pre-clinical studies. Int J Hyperthermia. 2018;35(1):398–418.
- K EJ, H T RG, C D. High intensity focused ultrasound: surgery of the future? Br J Radiol. 2003;76(909):590–599.
- Coveler AL, Mizrahi J, Eastman B, et al. Pancreas cancer-associated pain management. Oncologist. 2021;26(6):e971–e982.
- Dimitrov D, Stanislavova N, Yotsov T, et al. Recurrent pancreatic cancer patient treated by chemotherapy and focused ultrasound surgery. A case report. Med Ultrason. 2020;22(2):247–249.
- Marinova M, Huxold HC, Henseler J, et al. Clinical effectiveness and potential survival benefit of US-Guided High-Intensity focused ultrasound therapy in patients with advanced-stage pancreatic cancer. Ultraschall Med. 2019;40(5):625–637.
- Foley JL, Little JW, Vaezy S. Effects of high-intensity focused ultrasound on nerve conduction. Muscle Nerve. 2008;37(2):241–250.
- Gulati A, Loh J, Gutta NB, et al. Novel use of noninvasive high-intensity focused ultrasonography for intercostal nerve neurolysis in a swine model. Reg Anesth Pain Med. 2014;39(1):26–30.
- Brown MR, Farquhar-Smith P, Williams JE, et al. The use of high-intensity focused ultrasound as a novel treatment for painful conditions: a description and narrative review of the literature. Br J Anaesth. 2015;115(4):520–530.
- Sofuni A, Asai Y, Tsuchiya T, et al. Novel therapeutic method for unresectable pancreatic Cancer-The impact of the Long-Term research in therapeutic effect of high-intensity focused ultrasound (HIFU) therapy. Curr Oncol. 2021;28(6):4845–4861.
- Tao SF, Gu WH, Gu JC, et al. A retrospective case series of High-Intensity focused ultrasound (HIFU) in combination with gemcitabine and oxaliplatin (gemox) on treating elderly Middle and advanced pancreatic cancer. Onco Targets Ther. 2019;12:9735–9745.
- Sofuni A, Moriyasu F, Sano T, et al. Safety trial of high-intensity focused ultrasound therapy for pancreatic cancer. World J Gastroenterol. 2014;20(28):9570–9577.
- Li T, Chen H, Khokhlova T, et al. Passive cavitation detection during pulsed HIFU exposures of ex vivo tissues and in vivo mouse pancreatic tumors. Ultrasound Med Biol. 2014;40(7):1523–1534.